Arxada’s revenues in the third quarter were up 12% YoY whilst profitability remained flat due to a softer performance seen in the Microbial Control Solutions (MCS) segment. The Hygiene unit, which had propped up the company's results during the pandemic, was the main contributor to MSC’s disappointing quarterly result. Management for the microbial products producer (formerly known as Lonza Speciality Ingredients) were quick to point to customer destocking and softer demand in the travel industry as reasons for the 42% YoY revenue decline in the segment. A 20% rise in input costs was also destined to affect the Group’s result, however growth in their Specialty Products Solutions (SPS) markets managed to offset the reduction in margins.